SEGMENT INFORMATION AND GEOGRAPHIES (Tables)

12 Months Ended

Jul. 31, 2014

Segment Reporting [Abstract]

Segment Information

SEGMENT INFORMATION:	2014		2013		2012
SALES:
Life Sciences	$	1,453,669	$	1,309,375	$	1,253,594
Industrial	1,335,478		1,338,688		1,418,062
Total	$	2,789,147	$	2,648,063	$	2,671,656
SEGMENT PROFIT:
Life Sciences	357,129		319,271		319,312
Industrial	219,172		214,798		198,747
Total segment profit	576,301		534,069		518,059
Corporate Services Group	67,200		66,640		64,114
ROTC	40,154		40,182		66,858
Interest expense, net	17,532		15,621		20,177
Earnings before income taxes from continuing operations	$	451,415	$	411,626	$	366,910
DEPRECIATION AND AMORTIZATION:
Life Sciences	$	71,670	$	61,709	$	55,489
Industrial	43,217		42,641		45,419
Subtotal	114,887		104,350		100,908
Corporate Services Group	1,505		1,934		2,479
Total depreciation and amortization from continuing operations	$	116,392	$	106,284	$	103,387
CAPITAL EXPENDITURES:
Life Sciences	$	29,278	$	40,589	$	47,694
Industrial	34,226		33,551		26,227
Subtotal	63,504		74,140		73,921
Corporate/Shared Services Groups	11,233		36,042		84,988
Total	$	74,737	$	110,182	$	158,909
IDENTIFIABLE ASSETS:
Life Sciences	$	1,390,447	$	1,090,585	$	1,274,036
Industrial	1,000,843		898,064		955,541
Subtotal	2,391,290		1,988,649		2,229,577
Corporate/Shared Services Groups	1,461,223		1,484,190		1,118,315
Total	$	3,852,513	$	3,472,839	$	3,347,892
GEOGRAPHIC INFORMATION:
SALES:
Americas	$	889,122	$	849,486	$	839,984
Europe	1,140,429		1,034,515		1,022,952
Asia	759,596		764,062		808,720
Total	$	2,789,147	$	2,648,063	$	2,671,656

SEGMENT INFORMATION:	2014			2013			2012
IDENTIFIABLE ASSETS:
Americas	$	1,084,247		$	1,127,364		$	1,318,312
Europe	1,024,969			590,893			644,721
Asia	340,146			322,483			350,510
Eliminations	(58,072		)	(52,091		)	(83,966		)
Subtotal	2,391,290			1,988,649			2,229,577
Corporate/Shared Services Groups	1,461,223			1,484,190			1,118,315
Total	$	3,852,513		$	3,472,839		$	3,347,892